Stelitano Debora, Peche Leticia Yamila, Dalla Emiliano, Monte Martin, Piazza Silvano, Schneider Claudio
Laboratorio Nazionale del Consorzio Interuniversitario per le Biotecnologie (L.N.CIB), Trieste, Italy.
Laboratorio de Oncología Molecular, Departamento de Química Biológica and IQUIBICEN-UBA/CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.
Oncotarget. 2017 Jun 27;8(40):67422-67438. doi: 10.18632/oncotarget.18691. eCollection 2017 Sep 15.
GTSE1 over-expression has been reported as a potential marker for metastasis in various types of malignancies, including breast cancer. Despite this, the transcriptional regulation of this protein and the causes of its misregulation in tumors remain largely unknown. The aims of this work were to elucidate how GTSE1 is regulated at the transcriptional level and to clarify the mechanism underlying GTSE1-dependent cell functions in triple-negative breast cancer (TNBC). Here, we identified GTSE1 as a novel target gene of the TEAD4 transcription factor, highlighting a role for the YAP and TAZ coactivators in the transcriptional regulation of GTSE1. Moreover, we found that TEAD4 controls the formation of cell protrusions required for cell migration through GTSE1, unveiling a relevant effector role for this protein in the TEAD-dependent cellular functions and confirming TEAD4 role in promoting invasion and metastasis in breast cancer. Finally, we highlighted a role for the pRb-E2F1 pathway in the control of GTSE1 transcription and observed that treatment with drugs targeting the pRb-E2F1 or YAP/TAZ-TEAD pathways dramatically downregulated the expression levels of GTSE1 and of other genes involved in the formation of metastasis, suggesting their potential use in the treatment of TNBC.
GTSE1过表达已被报道为包括乳腺癌在内的多种恶性肿瘤转移的潜在标志物。尽管如此,该蛋白的转录调控及其在肿瘤中调控异常的原因仍大多未知。这项工作的目的是阐明GTSE1在转录水平上是如何被调控的,并阐明三阴性乳腺癌(TNBC)中依赖GTSE1的细胞功能的潜在机制。在此,我们确定GTSE1是TEAD4转录因子的一个新靶基因,突显了YAP和TAZ共激活因子在GTSE1转录调控中的作用。此外,我们发现TEAD4通过GTSE1控制细胞迁移所需的细胞突起的形成,揭示了该蛋白在依赖TEAD的细胞功能中的相关效应作用,并证实了TEAD4在促进乳腺癌侵袭和转移中的作用。最后,我们强调了pRb-E2F1通路在GTSE1转录调控中的作用,并观察到用靶向pRb-E2F1或YAP/TAZ-TEAD通路的药物治疗可显著下调GTSE1以及其他参与转移形成的基因的表达水平,表明它们在TNBC治疗中的潜在用途。